ARQT Q2 2020 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$57,000

Operating Income

-$36M

Net Income

-$35M

EPS (Diluted)

$-0.94

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$232M

Total Liabilities

$23M

Stockholders' Equity

$209M

Cash & Equivalents

$172M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$57,000	$0	—
Operating Income	-$36M	-$9M	-317.3%
Net Income	-$35M	-$8M	-327.2%